Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Mike Riepl"'
Autor:
Mike, Riepl
Publikováno v:
International journal of pharmaceutical compounding. 26(6)
Skin injuries, whether acute or chronic, can present therapeutic challenges engendered by wound type and etiology as well as the pharmacogenomic profile and treatment preferences of the patient. As a result, standardized manufactured medications may
Autor:
Mike, Riepl
Publikováno v:
International journal of pharmaceutical compounding. 26(5)
Cutaneous wounds that prove refractory to treatment with commercially manufactured medications impose a burden on patients, create challenges for the clinicians who treat them, and increase the cost of therapy. The success of pharmaceutical wound man
Autor:
Mike, Riepl
Publikováno v:
International journal of pharmaceutical compounding. 26(4)
The medical, economic, and social effects of painful chronic wounds such as anal fissures, which frequently prove refractory to treatment with commercially available medications, are often underestimated by clinicians. Those types of injuries, which
A Compendium of Compounding Agents and Formulations, Part 3: Gentamicin Sulfate and Benzoyl Peroxide
Autor:
Mike, Riepl
Publikováno v:
International journal of pharmaceutical compounding. 26(3)
Since antiquity, the safety and effectiveness of topical and transdermal medications in treating a host of somatic conditions, including disorders that afflict the skin, have been appreciated. Those drug-delivery forms offer convenient self-administr
Autor:
Mike, Riepl
Publikováno v:
International journal of pharmaceutical compounding. 26(2)
When compounded with synergistic ingredients, many pathogenicidal or anti-inflammatory drugs are particularly effective in resolving dermal or mucosal wounds that have proven refractory to treatment with standardized medications. In a customized prep
Autor:
Mike, Riepl
Publikováno v:
International journal of pharmaceutical compounding. 25(6)
The doses, dosage forms, and compositions of pharmaceutical compounds are as numerous and varied as the conditions for which they are prescribed. Although many patients in the U.S. have access to standardized medications that are effective, people wh
Autor:
Mike, Riepl
Publikováno v:
International journal of pharmaceutical compounding. 25(5)
Dermal healing occurs via a linear sequence of events in which growth factors cause cell proliferation and a subsequent integration of changes that involve soluble mediators, parenchymal and blood cells, and the production of extracellular matrix. My
Autor:
Mike, Riepl
Publikováno v:
International journal of pharmaceutical compounding. 25(4)
Diseases of and injuries to the human skin have been recognized since antiquity as health hazards that can increase morbidity and mortality and greatly compromise quality of life. The earliest effective treatments for such conditions and disorders we
Autor:
Mike, Riepl
Publikováno v:
International journal of pharmaceutical compounding. 25(2)
Healthy human skin performs a constellation of functions essential to good health, and the consequences of disruption to that effective external defense system have been recognized since antiquity. The earliest treatments for dermal injuries and dise
Autor:
Mike, Riepl
Publikováno v:
International journal of pharmaceutical compounding. 24(4)
Persistent diabetic foot ulcers can be difficult to treat. Success in doing so is based on understanding the differences between chronic- and acute-wound healing in general, the unique characteristics of those painful ulcers, and methods of treating